Dr Ramalingam has published over 100 peer reviewed articles and serves on the editorial board of leading cancer journals such as Journal of Clinical Oncology, Cancer and Clinical Lung Cancer. He has been an invited speaker at numerous international meetings.
Dr Ramalingam’s research interests include development of novel anti-cancer agents and evaluation of methods to individualize therapies to patients. He is currently involved in the development of agents that inhibit the mTOR, HDAC, DNA repair and EGFR pathways.
Dr Ramalingam is an active member of American Society of Clinical Oncology, the American Association for Cancer Research, and the International Association of Lung Cancer Study. He plays a leadership role in the ECOG-ACRIN Cancer Research Group as the Chair of the Thoracic Malignancies Committee. He has received many awards including the ‘ASCO Career Development Award’ (2006-09).
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!